BMO Capital raised the firm’s price target on Progressive to $200 from $185 and keeps an Outperform rating on the shares. The company’s pivot back to offensive growth when many of its peers continue to “heal” is highly likely in the coming months, aided by double-digit auto inflationary pressures decelerating off all-time highs, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PGR: